Nuveen
ZBH icon

Nuveen’s Zimmer Biomet ZBH Stock Holding History

Nuveen’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-26,265
Closed -$3K – 3373
2020
Q3 		$3K Hold
26,265
– – ﹤0.01% 3282
2020
Q2 		$3K Buy
+26,265
New +$3.03M ﹤0.01% 3247

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Nuveen's ZBH Position: Q2 2026 in Review

Nuveen reduced its Zimmer Biomet (ZBH) stake by 53% in Q2 2026, selling an estimated $46M and leaving 474,927 shares worth $40.9M. The position accounts for 0.01% of the portfolio, ranked #825.

Nuveen first reported a position in ZBH in Q2 2013 and has held it in 53 quarters since. The position peaked at $671M in Q4 2020. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Nuveen held 474,927 shares of Zimmer Biomet worth $40.9M as of Q2 2026.
  • Nuveen sold 524,985 Zimmer Biomet shares in Q2 2026, an estimated $46M.
  • Zimmer Biomet made up 0.01% of Nuveen's portfolio in Q2 2026, its #825 holding.
  • Nuveen first reported a position in Zimmer Biomet in Q2 2013 and has held it in 53 quarters since.
  • Nuveen's Zimmer Biomet position peaked at $671M in Q4 2020.
  • 909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.